INGR
Ingredion Incorporated
NYSEUSDEQUITY
Consumer Defensive
DELAYED
Last price
106.87
▼ 0.15 (0.14%)
MARKET · —
Price
Open
107.02
Prev close
107.02
Day high
108.06
Day low
106.69
Volume
299.37K
Market cap
$6.74B
P/E (TTM)
11.61
52W range
94.44 – 130.48
Trailing performance
Returnvs SPY
1W
+1.56%
+2.9%
1M
+6.57%
+2.8%
3M
+4.59%
+1.5%
6M
-8.81%
-19.9%
YTD
-3.10%
-15.4%
1Y
-15.71%
-35.7%
3Y
+9.27%
-64.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$6.74B
Enterprise value$7.57B
Revenue (TTM)$7.22B
Gross profit$1.71B
EBITDA$1.15B
Net income$592.00M
EPS (TTM)$9.20
Free cash flow$457.25M
Total cash$952.00M
Total debt$1.78B
Book value / share$71.70
Shares outstanding63.06M
Float62.58M
Short % of float8.35%
Dividend yield3.07%
Beta (5Y)0.61
Valuation & profitability ratios
Trailing P/E11.61
Forward P/E9.41
PEG ratio1.35
Price / sales—
Price / book1.49
EV / revenue1.05
EV / EBITDA6.56
Gross margin23.73%
Operating margin12.60%
Profit margin8.20%
Return on equity13.69%
Return on assets7.33%
Debt / equity39.41
Current ratio2.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $7.22B | $7.43B | $8.16B | $7.95B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $729.00M | $647.00M | $643.00M | $492.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $729.00M | $647.00M | $643.00M | $492.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.72 | 2.82 | +3.6% |
| Mar 2026 | 2.47 | 2.34 | -5.3% |
| Dec 2025 | 2.61 | 2.53 | -3.1% |
| Sep 2025 | 2.89 | 2.75 | -4.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.63 | 6 | $1.80B | -0.6% |
| Next quarter | 2.76 | 6 | $1.76B | +0.1% |
| Current year | 10.57 | 7 | $7.21B | -0.2% |
| Next year | 11.35 | 7 | $7.32B | +1.6% |
Analyst targets & ownership
Mean target$121.50
High target$150.00
Low target$108.00
Implied upside13.69%
Analyst count6
ConsensusHOLD
Strong buy / Buy1 / 1
Hold5
Sell / Strong sell0 / 0
Held by insiders0.89%
Held by institutions102.24%
Institutions holding800
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+86.01K
Net buying
Buy transactions
36
88.05K shares
Sell transactions
3
2.04K shares
Net transactions
+39
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
560.01K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 5, 26 | FISCHER DAVID B Director |
SELL | 1.66K | $170.04K | Direct |
| Jul 1, 26 | ESCOE T. KENNETH Director |
STOCK | 1.52K | $150.04K | Direct |
| May 20, 26 | FISCHER DAVID B Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | MAGRO CHARLES V. Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | TALBOT SIOBHAN Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | VERDUIN PATRICIA Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | REICH VICTORIA J Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | TANDA STEPHAN B Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | URIBE JORGE A Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | JORDAN RHONDA L Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | WILSON DWAYNE ANDREE Director |
STOCK | 1.80K | $192.89K | Direct |
| May 20, 26 | SUEVER CATHERINE A Director |
STOCK | 1.80K | $192.89K | Direct |
| Apr 16, 26 | TANDA STEPHAN B Director |
STOCK | 380 | $0 | Direct |
| Apr 15, 26 | URIBE JORGE A Director |
STOCK | 312 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FERNANDES LARRY |
Officer | 32.89K | Stock Award(Grant) |
GRAY JAMES D. |
Chief Financial Officer | 64.35K | Stock Award(Grant) |
JORDAN RHONDA L |
Director | 28.91K | Stock Award(Grant) |
KENNY GREGORY B |
Chairman of the Board | 66.66K | Stock Award(Grant) |
REICH VICTORIA J |
Director | 21.93K | Stock Award(Grant) |
RITCHIE ROBERT A |
Officer | 31.89K | Stock Award(Grant) |
SEIP DAVID ERIC |
Officer | 30.73K | Stock Award(Grant) |
URIBE JORGE A |
Director | 21.26K | Stock Award(Grant) |
WILSON DWAYNE ANDREE |
Director | 30.54K | Stock Award(Grant) |
ZALLIE JAMES P |
Chief Executive Officer | 135.37K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
105.22
+1.56% from price
SMA 20
103.68
+3.05% from price
SMA 50
100.96
+5.82% from price
SMA 100
104.34
+2.42% from price
SMA 200
108.40
-1.44% from price
EMA 12
105.08
+1.70% from price
EMA 26
103.56
+3.20% from price
EMA 50
102.93
+3.83% from price
RSI (14)
62.0
Neutral
MACD (12,26,9)
1.53
Hist 0.30
ATR (14)
2.15
2.01% of price
Realised vol 30D
21.6%
Annualised
Bollinger upper
107.99
20, 2σ
Bollinger lower
99.36
20, 2σ
50 / 200 cross
Death
100.96 vs 108.40
Trend bias
Below 200
-1.44%
Risk profile
Beta vs SPY
0.11
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
21.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.9%
Peak to trough
Max drawdown 5Y
-38.8%
Peak to trough
ATR 14
2.15
2.01% of price
Beta (reported)
0.61
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
8.33
Put-heavy session
Put / call open interest
1.03
Positioning, not flow
Max pain
100.00
-6.4% from spot
ATM implied vol
33.4%
Nearest strike to spot
Skew (10% OTM)
+4.8%
Puts bid over calls
Call volume
3
Contracts, this expiry
Put volume
25
Contracts, this expiry
Heaviest call OI
105.00
302 contracts
Heaviest put OI
100.00
329 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ingredion Names Diego Reynoso Chief Financial Officer
MT Newswires · 2d ago
Diego Reynoso to join Ingredion as Chief Financial Officer
GlobeNewswire · 2d ago
Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase – Quarterly Update Report
Exec Edge · 4d ago
5 Revealing Analyst Questions From Ingredion’s Q2 Earnings Call
StockStory · 10d ago
Q2 Earnings Roundup: Ingredion (NYSE:INGR) And The Rest Of The Ingredients, Flavors & Fragrances Segment
StockStory · 10d ago
Ingredion (INGR) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
3 AgTech & Food Innovation Stocks to Buy as the Industry Evolves
Zacks · 11d ago
Is Ingredion (INGR) Fully Valued After Reaffirming 2026 Guidance?
Simply Wall St. · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.